Erratum to: Int Urogynecol J

DOI 10.1007/s00192-009-0903-0

Incorrect data were given for the prevalence of clinically relevant POP. The correct overall presence of clinically relevant POP (≥ stage 2B) was 17.5% (n=114). Within this group, 30.7% (n=35) were symptomatic.

Furthermore, Table 4 was presented without the accompanying prognostic curve.

Table 4 The Slieker POP score chart and the prognostic index to read the sum score

The authors sincerely regret these errors.